OneDigital Investment Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210K Sell
714
-1,563
-69% -$443K ﹤0.01% 1488
2026
Q1
$635K Sell
2,277
-182
-7% -$52.4K 0.01% 854
2025
Q4
$745K Sell
2,459
-495
-17% -$154K 0.01% 780
2025
Q3
$828K Buy
2,954
+55
+2% +$15K 0.01% 731
2025
Q2
$700K Sell
2,899
-45
-2% -$10.6K 0.01% 770
2025
Q1
$717K Sell
2,944
-205
-7% -$61.7K 0.01% 729
2024
Q4
$1.03M Buy
3,149
+2,492
+379% +$846K 0.01% 626
2024
Q3
$220K Buy
+657
New +$209K ﹤0.01% 1320

Other funds holding BIO

OneDigital Investment Advisors's BIO Position: Q2 2026 in Review

OneDigital Investment Advisors reduced its Bio-Rad Laboratories Class A (BIO) stake by 69% in Q2 2026, selling an estimated $443K and leaving 714 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #1488.

OneDigital Investment Advisors first reported a position in BIO in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.03M in Q4 2024. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • OneDigital Investment Advisors held 714 shares of Bio-Rad Laboratories Class A worth $210K as of Q2 2026.
  • OneDigital Investment Advisors sold 1,563 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $443K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of OneDigital Investment Advisors's portfolio in Q2 2026, its #1488 holding.
  • OneDigital Investment Advisors first reported a position in Bio-Rad Laboratories Class A in Q3 2024 and has held it in 8 quarters since.
  • OneDigital Investment Advisors's Bio-Rad Laboratories Class A position peaked at $1.03M in Q4 2024.
  • 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on OneDigital Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.